What’s the big deal with ‘whole body gestational donation’? On defending bioethics

By J. Y. Lee. Over the past week, a flurry of articles on the internet (for example: 1, 2, 3) sensationalized the contents of a journal article published by philosopher Anna Smadjor, on what she calls  “Whole body gestational donation” – with discussants on social media largely condemning the proposed concept, and implying that “bioethics” […]

Read More…

How much credibility does my testimony deserve? This is not for an algorithm to decide!

By Giorgia Pozzi. The hype about the promises of machine learning (ML) systems in medicine is real, even though not always justified. As ethicists have been increasingly pointing out in the past years, quite some work still needs to be done to ensure their responsible use and safeguard fundamental bioethical principles, such as justice and […]

Read More…

Challenging lesser evil justifications for non-clinically indicated uses of antipsychotics in aged care facilities

By Hojjat Soofi. The administration of antipsychotic medications to residents with dementia in aged care facilities remains a subject of considerable controversy. A major focus of the controversy has been on the (questionable) influence that non-clinical considerations have on the rate of antipsychotic prescriptions in aged care facilities. Often, the primary beneficiaries of antipsychotic uses […]

Read More…

Troubles with trust

By Edwin Jesudason Our doctor says it’s something major, citing deadly-sounding results. We’re panicked. They talk about treatment options and evidence for each; about cherished benefits and gut-churning harms. They calmly seek our choice of treatment and our consent to proceed. Frozen, we don’t know which option to trust. A recent paper by philosophers at […]

Read More…

Prescribing growth hormone in pediatrics: The collision of history and medical ethics

By Rohan Henry In a 1958 editorial, the first case of growth hormone used as treatment for a medical condition was reported. Since that time, the administered product has changed from being pituitary derived specifically, cadaveric in origin, to recombinant human growth hormone in the United States which occurred in 1985.  With this practice shift, […]

Read More…

Making sense of value conflicts at the margins of the medical profession

By Henk Jasper van Gils-Schmidt and Sabine Salloch In our paper, “Taking a Moral Holiday? Physicians’ practical identities at the margins of professional ethics”, we discuss value conflicts that physicians come across at the margins of their professional practice. For example, the conflict one may experience as a psychiatrist when considering to speak out against a […]

Read More…